Skip to main content

Table 3 Factors associated with HBV suppression in HIV/HBV coinfected patients using multilevel logistic regressions

From: Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)

 

HBV viral load < 10 IU/mL

Univariate analysis

Multivariate analysis

n

(%)

OR

95% CI

p

Adjusted OR

95% CI

p

School educational level

 Lower than secondary

34

(63.0%)

1.00

  

1.00

  

 Secondary or higher

80

(77.7%)

2.04

0.97–4.27

0.058

2.31

1.05–5.07

0.037

CD4 cell count (per 100 cells/mm3 increase)

  

1.19

1.01–1.41

0.033

   

HIV viral load (copies/mL)

  ≥ 300

20

(54.1%)

1.00

  

1.00

  

  < 300

94

(78.3%)

3.26

1.42–7.46

0.005

3.46

1.48–8.09

0.004

ALT level (per 10 IU/L increase)

  

0.91

0.81–1.02

0.111

0.86

0.75–0.97

0.019

AST level (per 10 IU/L increase)

  

0.86

0.75–0.99

0.033

   

Time since ART initiation (per 5-year increase)

  

2.44

1.11–5.34

0.025

   

Duration of 3TC/FTC monotherapy (per 1-year increase)

  

1.18

1.01–1.36

0.042

   

Adherence to ART in the previous 4 weeks

 Perfect adherence

26

(59.9%)

1.00

     

 Adherence difficultiesa

60

(76.9%)

2.40

1.04–5.52

0.039

   

 Treatment interruption more than 2 consecutive days

28

(80.0%)

2.83

0.97–8.21

0.055

   

Region of study hospital

 Centre

74

(76.3%)

1.00

     

 Littoral

40

(66.7%)

0.58

0.25–1.35

0.206

0.42

0.19–0.96

0.039

Type of HIV service

 Primary

55

(64.7%)

1.00

  

1.00

  

 Secondary

59

(81.9%)

2.47

1.17–5.22

0.017

2.79

1.24–6.27

0.013

  1. Abbreviations: ART antiretroviral therapy, CI confidence interval, OR odds ratio, ALT Alanine aminotransferase, AST Aspartate aminotransferase
  2. a Missed prescribed drug doses or not fully respecting the prescription schedule
  3. The following characteristics were not associated with HBV suppression: gender; age; residence setting; marital status; paid activity; household monthly income; living below poverty line; number of meals per day; body mass index; anti-HBV drugs as part of ART; duration of current ART; hospitalization in the previous 3 months; consultation of a traditional healer in the previous 3 months; journey time to arrive at study hospital; setting and administrative sector of study hospital; task-shifting of ART prescription renewals or follow-up consultations to nurses; stock-out of ART in the previous 12 months